(E)- 4- (4- ((5- methyl- 2- phenyl- 1,3- oxazol- 4- yl)methoxy)benzyloxyimino)- 4- phenylbutyric acid

structure in first source

Also Known As:

TAK-559

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Acyclic Acids
    - Butyrates: 2613
      - (E)-4-(4-((5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy)benzyloxyimino)-4-phenylbutyric acid: 1
Lipids: 114793
- Fatty Acids: 27405
  - Volatile Fatty Acids: 3052
    - Butyrates: 2613
      - (E)-4-(4-((5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy)benzyloxyimino)-4-phenylbutyric acid: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Oxazoles: 89
      - (E)-4-(4-((5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy)benzyloxyimino)-4-phenylbutyric acid: 1

Experts

1.	Braileanu, Gheorghe T: 1 article (10/2007)
2.	Ding, Shi-Ying: 1 article (10/2007)
3.	Hansen, Barbara C: 1 article (10/2007)
4.	Ito, Katsuhiko: 1 article (10/2007)
5.	Tigno, Xenia T: 1 article (10/2007)

Related Diseases

1.	Dyslipidemias (Dyslipidemia) 10/01/2007 - "We investigated the effects of TAK-559 on dyslipidemia and insulin resistance in nonhuman primates. "
2.	Insulin Resistance 10/01/2007 - "We investigated the effects of TAK-559 on dyslipidemia and insulin resistance in nonhuman primates. " 10/01/2007 - "These results suggest that TAK-559 had beneficial effects on lipoprotein profiles and insulin sensitivity, without any side effect on body weight, which suggests that TAK-559 may provide a potentially safe approach for delaying the onset of type 2 diabetes mellitus and may reduce the risk of cardiovascular disease. "
3.	Type 2 Diabetes Mellitus (MODY) 10/01/2007 - "These results suggest that TAK-559 had beneficial effects on lipoprotein profiles and insulin sensitivity, without any side effect on body weight, which suggests that TAK-559 may provide a potentially safe approach for delaying the onset of type 2 diabetes mellitus and may reduce the risk of cardiovascular disease. "
4.	Cardiovascular Diseases (Cardiovascular Disease) 10/01/2007 - "These results suggest that TAK-559 had beneficial effects on lipoprotein profiles and insulin sensitivity, without any side effect on body weight, which suggests that TAK-559 may provide a potentially safe approach for delaying the onset of type 2 diabetes mellitus and may reduce the risk of cardiovascular disease. "
5.	Body Weight (Weight, Body) 10/01/2007 - "These results suggest that TAK-559 had beneficial effects on lipoprotein profiles and insulin sensitivity, without any side effect on body weight, which suggests that TAK-559 may provide a potentially safe approach for delaying the onset of type 2 diabetes mellitus and may reduce the risk of cardiovascular disease. "

Related Drugs and Biologics

1.	Lipoproteins (Lipoprotein)